September 15, 2009
What's New at
News & Views Library
Change/Update Subscription

Also Worth Noting: Breaking Research -- Coming Soon: ICAAC 2009 Highlights

ICAAC 2009, San Francisco, Sept. 12-15

What are the big stories to come out of one of the year's last major U.S.-based conferences to feature HIV-related research? Tune in to over the days to come as we provide coverage of ICAAC 2009, which took place this week in San Francisco, Calif. We'll have podcasts and interviews in which researchers discuss key studies as well as some of the most pressing issues in HIV medicine today.
 H1N1 Vaccine Update: Available in U.S. Earlier Than Expected; Only One Shot Needed
There's some good news on the H1N1 front: A vaccine may be available in the U.S. in just a few weeks, and you'll only need to take one shot instead of two. Both developments are welcome news in the U.S., where the H1N1 (swine flu) epidemic is heating up once again with the beginning of the school year. HIV-positive people are included among the "high-risk groups" that are being given priority to receive the H1N1 vaccine when it becomes available in the U.S. (Article from's experts have been answering questions about H1N1 and HIV/AIDS since the flu outbreak began. Check out our new "Frequently Asked Questions About H1N1 (Swine) Flu Virus" page for the answers you need to help you prepare for the coming flu season in the U.S. and the rest of the Northern Hemisphere.

For more information on the H1N1 flu, check out our interview with Joel Gallant, M.D., and browse through our collection of articles.

 Worldwide, Health Care Workers Are Often Sources of HIV Stigma and Discrimination, Report Says
Combating HIV stigma is no easy feat. More than 25 years into the HIV pandemic, it's a problem that is still prevalent around the world. And as a recent report outlines in vivid detail, even health care settings are rife with HIV stigma and discrimination, particularly in resource-poor countries. What's the key to turning this around? Fight ignorance with knowledge, the report urges. (Article from

 Share Your Comments in Support of HPV Vaccine Coverage for U.S. Boys and Young Men
The number of people who are able to receive the human papillomavirus (HPV) vaccine Gardasil may be about to double, but will the number of people who can afford to get it follow suit? An advisory panel to the U.S. Food and Drug Administration (FDA) has recommended that the vaccine be cleared for use not only in girls and young women, but in boys and young men as well. However, FDA approval is not the end of the road. Activists need you to take part in hearings next month over whether the federal government should pay for boys and young men to receive this vaccine through government-funded health programs such as Medicaid and Veterans Affairs. (Article from

Loreen Willenberg, an HIV controller and head of the Zephyr Foundation Unlocking the Mysteries of the HIV Controller: Take Part in a Day-Long San Francisco Event
What's the secret to keeping HIV miraculously under control without ever taking a single HIV med? That's what all of us want to know about the tiny percentage of HIVers who are called "HIV controllers." HIV controllers have some mysterious ingredient in their bodies that enables them to control HIV and stop it from progressing, without the help of HIV treatment. If you're one of these people or want to learn more about them, consider attending a day-long community event on Oct. 13 in San Francisco, Calif., hosted by the Zephyr Foundation. (Article from the Zephyr Foundation)
Photo: Loreen Willenberg, an HIV controller and head of the Zephyr Foundation

Activist Central

 Re-Authorize the Ryan White Act -- Care for People Living With HIV/AIDS

 Easy Steps to Impact U.S. HIV/AIDS Policy!

 Call Assembly Speaker Silver: Stop the HASA Rent Crisis -- New Yorkers With HIV/AIDS Need Affordable Housing!

 Tell Senators Health Care Reform Must Include Medicaid Parity for U.S. Territories!

 Petition for a Robust National Public Health Care Option and Expansion and Enhancement of Medicaid Coverage